{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"30.520","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"2,432,426,412","primaryexch":"HKEX","ric":"1530.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"B","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.8625,"inline_upper_strike_price":"","sedol":"BY9D3L9","am":"1.17","iv":"","ew_strike":"","as":"29.080","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"29.060","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-26 10:38:37.0","lo52":"5.470","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Lou Jing","underlying_ric":"1530.HK","hi52":"36.800","issuer_name":"3SBio Inc.","h_share_flag":false,"ew_sub_per_from":"","div_yield":"0.86","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"29.000","mkt_cap":"70.73","f_aum_hkd":null,"ew_sub_per_to":"","ls":"29.080","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-1.640","aum":"","issued_shares_class_B":null,"vo":"39.78","secondary_listing_flag":false,"listing_date":"11 Jun 2015","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"3SBio Inc.","nm_s":"3SBIO","sym":"1530","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.","op":"30.100","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Pharmaceuticals","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Room 1918, 19/F<br/>Lee Garden One<br/>33 Hysan Avenue<br/>Causeway Bay, Hong Kong","pc":"-5.34","days_to_expiry":null,"underlying_code":null,"pe":"31.84","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"30.720","isin":"KYG8875G1029","moneyness":""}},"qid":"1758889973798"}
